Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 19 | 2026 | 1136 | 3.710 |
Why?
|
| Biliary Atresia | 8 | 2026 | 224 | 2.000 |
Why?
|
| Immunosuppressive Agents | 5 | 2026 | 655 | 0.910 |
Why?
|
| Adenovirus Infections, Human | 1 | 2026 | 61 | 0.910 |
Why?
|
| Adenoviridae Infections | 1 | 2026 | 76 | 0.910 |
Why?
|
| Zellweger Syndrome | 1 | 2024 | 16 | 0.870 |
Why?
|
| Polyneuropathies | 1 | 2024 | 30 | 0.860 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2025 | 59 | 0.840 |
Why?
|
| Liver Diseases | 4 | 2026 | 378 | 0.830 |
Why?
|
| Graft Rejection | 6 | 2026 | 558 | 0.790 |
Why?
|
| Cholestasis | 1 | 2025 | 170 | 0.750 |
Why?
|
| Postoperative Complications | 3 | 2026 | 3113 | 0.680 |
Why?
|
| Herpesvirus 6, Human | 1 | 2021 | 53 | 0.660 |
Why?
|
| Cytokines | 2 | 2026 | 1342 | 0.650 |
Why?
|
| Organ Transplantation | 1 | 2021 | 171 | 0.570 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 2018 | 19 | 0.570 |
Why?
|
| Transplant Recipients | 4 | 2026 | 229 | 0.560 |
Why?
|
| Blood Group Incompatibility | 1 | 2018 | 28 | 0.560 |
Why?
|
| ABO Blood-Group System | 1 | 2018 | 61 | 0.550 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 221 | 0.540 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2017 | 14 | 0.540 |
Why?
|
| Child | 23 | 2026 | 26181 | 0.530 |
Why?
|
| Neonatal Screening | 1 | 2019 | 204 | 0.520 |
Why?
|
| Hepatitis B, Chronic | 1 | 2018 | 84 | 0.510 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2017 | 143 | 0.500 |
Why?
|
| Immunologic Memory | 1 | 2017 | 197 | 0.480 |
Why?
|
| Capsule Endoscopy | 2 | 2012 | 16 | 0.450 |
Why?
|
| Contrast Media | 2 | 2024 | 473 | 0.450 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 611 | 0.440 |
Why?
|
| Hepatitis C, Chronic | 1 | 2018 | 356 | 0.420 |
Why?
|
| Alagille Syndrome | 2 | 2025 | 54 | 0.400 |
Why?
|
| Fatty Liver | 2 | 2025 | 218 | 0.390 |
Why?
|
| Humans | 37 | 2026 | 130154 | 0.370 |
Why?
|
| DNA, Viral | 2 | 2024 | 452 | 0.340 |
Why?
|
| Constipation | 1 | 2012 | 131 | 0.330 |
Why?
|
| Medication Adherence | 2 | 2026 | 336 | 0.330 |
Why?
|
| Child, Preschool | 10 | 2026 | 15009 | 0.320 |
Why?
|
| Retrospective Studies | 12 | 2026 | 17554 | 0.310 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2025 | 400 | 0.300 |
Why?
|
| Infant | 10 | 2026 | 13276 | 0.290 |
Why?
|
| Incidence | 3 | 2026 | 3314 | 0.270 |
Why?
|
| Chickenpox Vaccine | 2 | 2024 | 14 | 0.260 |
Why?
|
| Female | 20 | 2026 | 70285 | 0.260 |
Why?
|
| Chickenpox | 2 | 2024 | 22 | 0.250 |
Why?
|
| Vaccines, Attenuated | 2 | 2024 | 174 | 0.250 |
Why?
|
| Measles | 2 | 2024 | 39 | 0.250 |
Why?
|
| Male | 18 | 2026 | 64397 | 0.230 |
Why?
|
| Atlases as Topic | 1 | 2025 | 19 | 0.230 |
Why?
|
| Sarcopenia | 1 | 2026 | 55 | 0.230 |
Why?
|
| Bile Acids and Salts | 2 | 2025 | 260 | 0.230 |
Why?
|
| Nutritional Support | 1 | 2025 | 67 | 0.220 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1485 | 0.220 |
Why?
|
| Measles Vaccine | 1 | 2024 | 11 | 0.210 |
Why?
|
| Herpesvirus 3, Human | 1 | 2024 | 29 | 0.210 |
Why?
|
| Parenteral Nutrition | 1 | 2025 | 219 | 0.200 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2024 | 26 | 0.200 |
Why?
|
| Mumps | 1 | 2023 | 11 | 0.200 |
Why?
|
| Immunocompromised Host | 1 | 2026 | 310 | 0.200 |
Why?
|
| Follow-Up Studies | 4 | 2026 | 5161 | 0.200 |
Why?
|
| Rubella | 1 | 2023 | 17 | 0.200 |
Why?
|
| Adolescent | 10 | 2026 | 20802 | 0.200 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2025 | 215 | 0.200 |
Why?
|
| Biomarkers | 4 | 2026 | 3360 | 0.200 |
Why?
|
| Sirolimus | 1 | 2025 | 231 | 0.200 |
Why?
|
| Gadolinium | 1 | 2024 | 109 | 0.200 |
Why?
|
| Liver | 3 | 2025 | 1788 | 0.200 |
Why?
|
| Enteral Nutrition | 1 | 2025 | 286 | 0.190 |
Why?
|
| Cholangitis | 1 | 2023 | 38 | 0.190 |
Why?
|
| Biopsy | 2 | 2025 | 1237 | 0.190 |
Why?
|
| Interleukin-12 | 1 | 2023 | 124 | 0.180 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2025 | 289 | 0.180 |
Why?
|
| RNA, Viral | 1 | 2024 | 499 | 0.180 |
Why?
|
| Herpesvirus 4, Human | 1 | 2025 | 639 | 0.180 |
Why?
|
| Liver Failure, Acute | 1 | 2023 | 95 | 0.180 |
Why?
|
| Gastrointestinal Motility | 2 | 2012 | 61 | 0.170 |
Why?
|
| Monocytes | 1 | 2023 | 335 | 0.170 |
Why?
|
| Viral Vaccines | 1 | 2023 | 322 | 0.160 |
Why?
|
| Prevalence | 2 | 2026 | 2685 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2026 | 800 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2023 | 410 | 0.160 |
Why?
|
| Aedes | 1 | 2020 | 103 | 0.160 |
Why?
|
| Dendritic Cells | 1 | 2023 | 435 | 0.160 |
Why?
|
| Macrophages | 1 | 2024 | 660 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2026 | 556 | 0.150 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2020 | 62 | 0.150 |
Why?
|
| Prognosis | 4 | 2026 | 4848 | 0.150 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 208 | 0.150 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2019 | 26 | 0.150 |
Why?
|
| Purpura | 1 | 2019 | 25 | 0.140 |
Why?
|
| Cytomegalovirus | 1 | 2020 | 258 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2026 | 831 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2026 | 6403 | 0.140 |
Why?
|
| Chronic Disease | 4 | 2026 | 1241 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2024 | 1440 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 519 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2018 | 229 | 0.130 |
Why?
|
| Pediatrics | 1 | 2026 | 1242 | 0.120 |
Why?
|
| Branchial Region | 1 | 2015 | 9 | 0.120 |
Why?
|
| Pharyngeal Muscles | 1 | 2015 | 10 | 0.120 |
Why?
|
| Infant, Newborn | 2 | 2019 | 8551 | 0.120 |
Why?
|
| Oropharynx | 1 | 2015 | 31 | 0.120 |
Why?
|
| Pharyngeal Diseases | 1 | 2015 | 17 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 239 | 0.110 |
Why?
|
| Polyps | 1 | 2015 | 38 | 0.110 |
Why?
|
| Inflammation | 1 | 2023 | 1481 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1166 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 461 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3744 | 0.110 |
Why?
|
| Nutritional Status | 2 | 2026 | 298 | 0.100 |
Why?
|
| End Stage Liver Disease | 2 | 2026 | 193 | 0.100 |
Why?
|
| Graft Survival | 2 | 2026 | 466 | 0.100 |
Why?
|
| Celiac Disease | 1 | 2013 | 73 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2024 | 12843 | 0.090 |
Why?
|
| Gastrointestinal Transit | 1 | 2011 | 28 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2013 | 316 | 0.080 |
Why?
|
| Gastroenterology | 1 | 2013 | 223 | 0.080 |
Why?
|
| Risk Factors | 4 | 2026 | 10953 | 0.080 |
Why?
|
| Aged | 3 | 2017 | 20833 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2011 | 337 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 776 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2079 | 0.060 |
Why?
|
| Pregnancy | 1 | 2019 | 7396 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2024 | 3350 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2026 | 234 | 0.060 |
Why?
|
| Adult | 3 | 2026 | 31042 | 0.050 |
Why?
|
| Measles virus | 1 | 2024 | 16 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2026 | 276 | 0.050 |
Why?
|
| Middle Aged | 3 | 2026 | 28331 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2025 | 234 | 0.050 |
Why?
|
| Waiting Lists | 1 | 2026 | 250 | 0.050 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 40 | 0.050 |
Why?
|
| Consensus | 1 | 2026 | 520 | 0.050 |
Why?
|
| Energy Intake | 1 | 2025 | 502 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2025 | 338 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 157 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2024 | 171 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2026 | 445 | 0.050 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 151 | 0.040 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2025 | 497 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 231 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2026 | 790 | 0.040 |
Why?
|
| Phenotype | 2 | 2023 | 4464 | 0.040 |
Why?
|
| Oviposition | 1 | 2020 | 6 | 0.040 |
Why?
|
| Mosquito Vectors | 1 | 2020 | 34 | 0.040 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2019 | 6 | 0.040 |
Why?
|
| Consanguinity | 1 | 2019 | 115 | 0.040 |
Why?
|
| Vaccination | 1 | 2024 | 1056 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 398 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 1177 | 0.030 |
Why?
|
| RNA | 1 | 2020 | 511 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 283 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2026 | 3680 | 0.030 |
Why?
|
| Registries | 1 | 2023 | 1610 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 902 | 0.030 |
Why?
|
| Vomiting | 1 | 2015 | 103 | 0.030 |
Why?
|
| Epithelium | 1 | 2015 | 336 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2015 | 126 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2023 | 5042 | 0.030 |
Why?
|
| Airway Obstruction | 1 | 2015 | 173 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2013 | 124 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 2013 | 151 | 0.020 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 250 | 0.020 |
Why?
|
| Iowa | 1 | 2011 | 13 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 113 | 0.020 |
Why?
|
| Animals | 2 | 2024 | 33698 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 18172 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 2289 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 6070 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6768 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 9987 | 0.010 |
Why?
|